Swissfillon AG, a fill and finish contract manufacturing organization (CMO) for complex pharmaceutical and biopharmaceutical products, has successfully completed a facility inspection of its GMP manufacturing site, located in Visp, Switzerland.   The Swissfillon production site in Visp was assessed by the U.S. FDA between April 15 and 24, 2019. The focus was on the fill and finish process related to a highly delicate drug product and produced an overall positive evaluation from the auditors.   S...